NHS England stalls plans for HIV prevention drug Consultation on Truvada will now be shelved, in move sexual health charities have described as ‘shameful’ and ‘failing those at risk’ of HIV.
Charities and campaigners have reacted with anger and disbelief that plans to roll out a widely anticipated HIV prevention drug have been stalled by NHS England.
The sector had been waiting for the announcement of the first ever public consultation on the use of pre-exposure prophylaxis (PrEP) in the UK, now overdue by a month. Instead today NHS England announced it was not their responsibility to commission the drug. Continue reading... The Guardian
See also:
Charities and campaigners have reacted with anger and disbelief that plans to roll out a widely anticipated HIV prevention drug have been stalled by NHS England.
The sector had been waiting for the announcement of the first ever public consultation on the use of pre-exposure prophylaxis (PrEP) in the UK, now overdue by a month. Instead today NHS England announced it was not their responsibility to commission the drug. Continue reading... The Guardian
See also:
- Update on commissioning and provision of Pre Exposure Prophylaxsis (PREP) for HIV prevention NHS England
- Could a monthly injection prevent HIV? Single shot of PrEP drugs is 'as effective as taking pills twice a day' The Daily Mail
- Daily pill Truvada cuts spread of HIV by 86%, study shows The Guardian
- NHS England slammed for 'u-turn' on new HIV treatment ITV News
No comments:
Post a Comment